Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
29.7M
-
Shares change
-
-495K
-
Total reported value, excl. options
-
$416M
-
Value change
-
-$2.75M
-
Number of buys
-
31
-
Number of sells
-
-27
-
Price
-
$13.99
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q3 2017
72 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q3 2017.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.7M shares
.
Largest 10 shareholders include NEA Management Company, LLC (8.58M shares), WELLINGTON MANAGEMENT GROUP LLP (3.49M shares), BVF INC/IL (3.23M shares), FRANKLIN RESOURCES INC (1.86M shares), JENNISON ASSOCIATES LLC (1.59M shares), FMR LLC (1.48M shares), Redmile Group, LLC (1.21M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.1M shares), VANGUARD GROUP INC (923K shares), and MILLENNIUM MANAGEMENT LLC (685K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.